FDA Inspection
Hikma Pharmaceuticals USA INC.Hikma Pharmaceuticals USA INC. – FDA Inspection, Jan 17, 2025
Record Details
This FDA Inspection record concerns Hikma Pharmaceuticals USA INC., with an inspection on January 17, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · be288e60-3b18-493f-bcd2-c5d2f1ca4059
Inspection Facts
- Inspection number
- 1238509
- FDA center
- Human Drugs
Other FDA inspections of Hikma Pharmaceuticals USA INC.
27| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | Cincinnati District Office | |
| April 30, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2024 | NAI | Compliance: Devices | |
| September 15, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hikma Pharmaceuticals USA INC.
- FDA Inspection 1285748 - 2026-09-18
- FDA Inspection 1303412 - 2026-04-30
- FDA Inspection 1243797 - 2024-07-23
- FDA Inspection 1182363 - 2022-09-15
- FDA Inspection 1113855 - 2019-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.